46 related articles for article (PubMed ID: 31266544)
1. A case of anti-SAE1/2 antibody-positive dermatomyositis with extensive panniculitis: A possible cutaneous manifestation of treatment resistance.
Fujisaki M; Kasamatsu H; Nishimura K; Yoshida Y; Muneishi Y; Yamaguchi T; Nishino I; Konishi R; Ichimura Y; Okiyama N; Oyama N; Hasegawa M
J Dermatol; 2024 Feb; 51(2):301-306. PubMed ID: 37830399
[TBL] [Abstract][Full Text] [Related]
2. Anti-Mi-2 antibody-positive dermatomyositis following Spirulina intake.
Kuzumi A; Yoshizaki A; Kawanabe R; Sato S
Rheumatology (Oxford); 2024 Mar; ():. PubMed ID: 38486347
[No Abstract] [Full Text] [Related]
3. Pathologic Features of Anti-Mi-2 Dermatomyositis.
Neurology; 2023 Apr; 100(15):738. PubMed ID: 36693731
[No Abstract] [Full Text] [Related]
4. Social, Disease, and Diagnostic Factors Associated with Diagnostic Delays in Dermatomyositis: A Retrospective Cohort Study.
Wanberg LJ; Singhe N; Rasner CJ; McGrath J; Jiang Z; Baker-James K; Buechler CR; Pearson DR
Br J Dermatol; 2024 Jun; ():. PubMed ID: 38860557
[No Abstract] [Full Text] [Related]
5. Anti-Mi-2 antibodies characterize a distinct clinical subset of dermatomyositis with favourable prognosis.
Liang L; Zhang YM; Chen H; Ye LF; Li SS; Lu X; Wang GC; Peng QL
Eur J Dermatol; 2020 Apr; ():. PubMed ID: 32293565
[TBL] [Abstract][Full Text] [Related]
6. Current Biomarker Strategies in Autoimmune Neuromuscular Diseases.
Oeztuerk M; Henes A; Schroeter CB; Nelke C; Quint P; Theissen L; Meuth SG; Ruck T
Cells; 2023 Oct; 12(20):. PubMed ID: 37887300
[TBL] [Abstract][Full Text] [Related]
7. Myositis interstitial lung disease and autoantibodies.
Chaudhry S; Christopher-Stine L
Front Med (Lausanne); 2023; 10():1117071. PubMed ID: 37384043
[TBL] [Abstract][Full Text] [Related]
8. Clinical manifestations, outcomes, and antibody profile of Brazilian adult patients with dermatomyositis: a single-center longitudinal study.
Truzzi NCC; Hoff LS; Borges IBP; de Souza FHC; Shinjo SK
Adv Rheumatol; 2022 Nov; 62(1):41. PubMed ID: 36371389
[TBL] [Abstract][Full Text] [Related]
9. Anti-Mi2 Antibody Positive Dermatomyositis With Hyper-Elevated Creatine Kinase: A Case Report.
Ohta R; Yoshioka N; Yamane F; Hayashi M; Sano C
Cureus; 2022 Sep; 14(9):e28899. PubMed ID: 36237748
[TBL] [Abstract][Full Text] [Related]
10. A Man With Recurrent Pneumonitis: A Rare Case of Interstitial Lung Disease Associated With Anti-Mi-2 Beta-Specific Dermatomyositis.
Ahmad A; Attoti Y; Bernstein KA
Cureus; 2021 Dec; 13(12):e20334. PubMed ID: 35028227
[TBL] [Abstract][Full Text] [Related]
11. NanoString technology distinguishes anti-TIF-1γ
Preusse C; Eede P; Heinzeling L; Freitag K; Koll R; Froehlich W; Schneider U; Allenbach Y; Benveniste O; Schänzer A; Goebel HH; Stenzel W; Radke J
Brain Pathol; 2021 May; 31(3):e12957. PubMed ID: 34043263
[TBL] [Abstract][Full Text] [Related]
12. Dermatomyositis autoantibodies: how can we maximize utility?
Hodgkinson LM; Wu TT; Fiorentino DF
Ann Transl Med; 2021 Mar; 9(5):433. PubMed ID: 33842654
[TBL] [Abstract][Full Text] [Related]
13. More prominent muscle involvement in patients with dermatomyositis with anti-Mi2 autoantibodies.
Pinal-Fernandez I; Mecoli CA; Casal-Dominguez M; Pak K; Hosono Y; Huapaya J; Huang W; Albayda J; Tiniakou E; Paik JJ; Johnson C; Danoff SK; Corse AM; Christopher-Stine L; Mammen AL
Neurology; 2019 Nov; 93(19):e1768-e1777. PubMed ID: 31594859
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of clinical characteristics and laboratory parameters of patients with dermatomyositis-specific autoantibodies and autoantibody-negative patients].
Bodoki L; Budai D; Nagy-Vincze M; Griger Z; Betteridge Z; Dankó K
Orv Hetil; 2015 Sep; 156(36):1451-9. PubMed ID: 26320599
[TBL] [Abstract][Full Text] [Related]
15. The relevance of anti-Jo-1 autoantibodies in patients with definite dermatomyositis.
de Andrade VP; De Souza FHC; Behrens Pinto GL; Shinjo SK
Adv Rheumatol; 2021 Feb; 61(1):12. PubMed ID: 33608062
[TBL] [Abstract][Full Text] [Related]
16. [Dermatomyositis-specific antibodies].
Bodoki L; Nagy-Vincze M; Griger Z; Dankó K
Z Rheumatol; 2015 May; 74(4):363-9. PubMed ID: 25644067
[TBL] [Abstract][Full Text] [Related]
17. Four dermatomyositis-specific autoantibodies-anti-TIF1γ, anti-NXP2, anti-SAE and anti-MDA5-in adult and juvenile patients with idiopathic inflammatory myopathies in a Hungarian cohort.
Bodoki L; Nagy-Vincze M; Griger Z; Betteridge Z; Szöllősi L; Dankó K
Autoimmun Rev; 2014 Dec; 13(12):1211-9. PubMed ID: 25182203
[TBL] [Abstract][Full Text] [Related]
18. Frequency and clinical relevance of anti-Mi-2 autoantibody in adult Brazilian patients with dermatomyositis.
Dos Passos Carvalho MIC; Shinjo SK
Adv Rheumatol; 2019 Jul; 59(1):27. PubMed ID: 31266544
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
